What surgery for perihilar cholangiocarcinoma no lymph node invasion

June 29, 2026Navis AI

Ask Navis about your situation

This answer is general. Get one about your specific case — no signup, answered right here.

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

TL;DR: Surgery is the main treatment for perihilar cholangiocarcinoma without lymph node spread, and the type depends on how far the cancer has grown into the bile ducts and nearby structures—your surgeon will decide the best approach after imaging.

KEY POINTS:

  • Perihilar cholangiocarcinoma (cancer where bile ducts meet near the liver) is treated with surgery when possible, especially if lymph nodes aren't involved
  • The most common surgery is hepatic resection (removing part of the liver) combined with bile duct resection (removing the affected ducts)
  • Surgeons may also remove the gallbladder and surrounding lymph nodes to reduce cancer recurrence risk
  • The exact extent of surgery depends on tumor location, size, and how deeply it invades nearby structures—determined by CT/MRI imaging
  • Liver function and overall health are critical factors in deciding if you're a surgical candidate

NEXT STEP: Ask your surgical oncologist: "Based on my imaging, what type of resection do you recommend, and what will be removed?"


[[FULL_ANSWER]]

Understanding Perihilar Cholangiocarcinoma Surgery

Perihilar cholangiocarcinoma is cancer that starts in the bile ducts at the hilum—the area where the left and right hepatic ducts meet near the liver. The fact that your lymph nodes are not involved is favorable for surgical outcomes, as it suggests the cancer hasn't spread regionally.

Why Surgery Is the Primary Treatment

According to NCCN Guidelines for Bile Duct Cancer, surgery offers the only realistic chance for cure in cholangiocarcinoma. For patients without distant metastases (spread to distant organs) and without major lymph node involvement, resection is the standard approach.

Types of Surgery for Perihilar Cholangiocarcinoma

1. Hepatic Resection + Bile Duct Resection (Most Common)

  • Hepatic resection means removing a portion of the liver (usually the right or left lobe, depending on tumor location)
  • Bile duct resection removes the affected bile ducts
  • This combined approach is necessary because perihilar tumors often grow into both the liver tissue and the bile ducts themselves
  • The extent depends on Bismuth classification (a staging system based on how far up the bile ducts the cancer extends)

2. Extent Variations Based on Tumor Location:

  • Bismuth Type I/II (lower perihilar): May require less extensive liver resection
  • Bismuth Type III/IV (higher perihilar): Often requires more extensive resection, sometimes involving both liver lobes
  • Your surgeon will determine this from your CT or MRI imaging

3. Additional Structures Often Removed:

  • Gallbladder (cholecystectomy) — routinely removed
  • Regional lymph nodes — removed and examined to confirm no spread
  • Hepatic artery or portal vein — may be resected if tumor invades these vessels (more complex surgery)

Surgical Decision-Making Factors

Your surgeon evaluates:

  • Tumor extent — how far it has invaded into liver, ducts, and blood vessels
  • Liver function — can your remaining liver handle normal function?
  • Performance status — your overall health and ability to tolerate major surgery
  • Resectability — whether the tumor can be completely removed with adequate margins (normal tissue around it)

What Happens After Surgery

According to ASCO Guidelines on Cholangiocarcinoma, patients typically receive:

  • Adjuvant chemotherapy (chemotherapy after surgery) — often recommended to reduce recurrence risk, even without lymph node involvement
  • Pathology review — the removed tissue is examined to confirm complete resection and guide further treatment decisions
  • Follow-up imaging — CT or MRI scans to monitor for recurrence

Important Considerations

  • Liver regeneration: The remaining liver can regrow to near-normal size over 3-6 months
  • Morbidity: Major hepatic resection carries risks including infection, bleeding, and liver failure—your surgeon will discuss these
  • Neoadjuvant therapy: Some centers use chemotherapy before surgery to shrink tumors or improve resectability; ask if this is an option for you

Questions to Ask Your Surgical Oncologist

  1. Based on my imaging, what is my Bismuth classification, and how does that affect the surgery you recommend?
  2. Will you remove the right lobe, left lobe, or both? Why?
  3. What is your estimate of my risk for major complications, and how do you manage them?
  4. After surgery, will I need chemotherapy? If so, what regimen?
  5. What is your experience with this specific type of resection, and what are your outcomes?

Authoritative Resources

  • NCCN Guidelines for Bile Duct Cancer — comprehensive surgical and systemic treatment recommendations
  • American Cancer Society — patient-friendly information on cholangiocarcinoma treatment
  • ASCO Clinical Practice Guidelines — evidence-based recommendations for adjuvant therapy

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

Ask Navis about your case

That answer is general. Ask about your specific situation — no signup, answered right here.

Facing this with someone you love?

Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.

Start a care circle →

Related Questions

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

We are in the UK royal marsden. It is kind of hopeless or how to say? Is there any immunetherapy worth to pursue or...

TL;DR: Diffuse midline gliomas DMGs with H3K27M are very challenging, but immunotherapy and targeted approaches are actively being researched—the Roya

It is my daughter she completed 6 weeks of radio and tmz now she is on 3rd cycle of tmz 200mg. We are doing low meth...

TL;DR: Your daughter's treatment plan radiation + TMZ chemotherapy is standard for diffuse midline glioma, and her biomarkers MGMT methylated, EGFR A2

It is h3k27 altered dmg h3k27m negative, egfr a289v myc tp53 mgmt methylated

Your tumor has specific genetic changes H3K27, EGFR, MYC, TP53, MGMT that your doctors will use to guide treatment decisions—these findings help deter